OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis
Shan Lei, Wenpeng Cao, Zhirui Zeng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 39
Shan Lei, Wenpeng Cao, Zhirui Zeng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 39
Showing 26-50 of 39 citing articles:
UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells
Guo Long, Zheyu Wu, Dong Wang, et al.
Free Radical Biology and Medicine (2023) Vol. 212, pp. 162-173
Closed Access | Times Cited: 4
Guo Long, Zheyu Wu, Dong Wang, et al.
Free Radical Biology and Medicine (2023) Vol. 212, pp. 162-173
Closed Access | Times Cited: 4
Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy
Manuel Scimeca, Valentina Rovella, Valeria Palumbo, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3638-3638
Open Access | Times Cited: 3
Manuel Scimeca, Valentina Rovella, Valeria Palumbo, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3638-3638
Open Access | Times Cited: 3
Revision of potential prognostic markers of cholangiocarcinoma for clinical practice
Charupong Saengboonmee, Sumalee Obchoei, Kanlayanee Sawanyawisuth, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 5, pp. 517-530
Closed Access | Times Cited: 2
Charupong Saengboonmee, Sumalee Obchoei, Kanlayanee Sawanyawisuth, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 5, pp. 517-530
Closed Access | Times Cited: 2
Ferroptosis and cancer: interlinkages and potential applications
Xiaofeng Hu, Jun Jiang
Clinical and translational reports (2023)
Open Access | Times Cited: 2
Xiaofeng Hu, Jun Jiang
Clinical and translational reports (2023)
Open Access | Times Cited: 2
Identification of novel ferroptosis-related biomarkers associated with the oxidative stress pathways in ischemic cardiomyopathy
Huilin Liu, Yuan Xu, Yuanmei Liu, et al.
IJC Heart & Vasculature (2024) Vol. 56, pp. 101584-101584
Open Access
Huilin Liu, Yuan Xu, Yuanmei Liu, et al.
IJC Heart & Vasculature (2024) Vol. 56, pp. 101584-101584
Open Access
ACSL3 is an unfavorable prognostic marker in cholangiocarcinoma patients and confers ferroptosis resistance in cholangiocarcinoma cells
Apiwit Sae-Fung, Nawaporn Vinayavekhin, Bengt Fadeel, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Apiwit Sae-Fung, Nawaporn Vinayavekhin, Bengt Fadeel, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer
Runhua Tang, Haoran Wang, Jianyong Liu, et al.
Research Square (Research Square) (2024)
Open Access
Runhua Tang, Haoran Wang, Jianyong Liu, et al.
Research Square (Research Square) (2024)
Open Access
The Potential Role of Non-coding RNAs in Regulating Ferroptosis in Cancer: Mechanisms and Application Prospects
Ming-Yuan Cao, Zhendong Zhang, Xin-Rui Hou, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 16, pp. 1182-1196
Closed Access
Ming-Yuan Cao, Zhendong Zhang, Xin-Rui Hou, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 16, pp. 1182-1196
Closed Access
Emerging insights into ferroptosis in cholangiocarcinoma (Review)
Xiaoyue Zhao, Miao Zhang, Jing He, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
Xiaoyue Zhao, Miao Zhang, Jing He, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
The Disulfidptosis-Mediated Intercellular Communication in the Tumor Microenvironment Contributes to the Progression of Osteosarcoma and Immunotherapy
Yueying Xiao, Tianze Zhang, J. Wang, et al.
(2023)
Open Access | Times Cited: 1
Yueying Xiao, Tianze Zhang, J. Wang, et al.
(2023)
Open Access | Times Cited: 1
Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCA
Runhua Tang, Haoran Wang, Jianyong Liu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Runhua Tang, Haoran Wang, Jianyong Liu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
An integrated mRNA–lncRNA signature for overall survival prediction in cholangiocarcinoma
Derong Xu, Lili Wei, Liping Zeng, et al.
Medicine (2023) Vol. 102, Iss. 39, pp. e35348-e35348
Open Access
Derong Xu, Lili Wei, Liping Zeng, et al.
Medicine (2023) Vol. 102, Iss. 39, pp. e35348-e35348
Open Access
FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis
Shan Lei, Wenpeng Cao, Xiaozong Chen, et al.
Research Square (Research Square) (2023)
Open Access
Shan Lei, Wenpeng Cao, Xiaozong Chen, et al.
Research Square (Research Square) (2023)
Open Access
Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancer
Runhua Tang, Haoran Wang, Jianyong Liu, et al.
Research Square (Research Square) (2023)
Open Access
Runhua Tang, Haoran Wang, Jianyong Liu, et al.
Research Square (Research Square) (2023)
Open Access
